EMILY STOY: Open Payments
NPI 1215378260 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 104 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $532 · 2025 $2,023
Food & beverage: $2,023
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $551 |
| PFIZER INC. | 13 | $275 |
| Novo Nordisk Inc | 14 | $250 |
| GlaxoSmithKline, LLC. | 11 | $232 |
| Lilly USA, LLC | 11 | $194 |
| AstraZeneca Pharmaceuticals LP | 6 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| Boston Scientific Corporation | 2 | $51 |
| Abbott Laboratories | 2 | $46 |
| ABIOMED | 1 | $42 |
Products named: QULIPTA, VRAYLAR, ELIQUIS, MOUNJARO, TRELEGY ELLIPTA, SHINGRIX, Wegovy, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
